Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +25.3% | -79.6% | 1 / 3 | -3.0% | -17.38 pp | +24.39 pp | — | 0.10 | — | 37,4 | −3,0% | −27,4 | +27,2% | — | 4.05 | — |
| Pts | 4 | 0 | 4 | 0 | 0 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.200 (close price on 2026-10-19)EPS (TTM): −376,4
Financial charts
1.Revenue & growth
VND bn37,4Q2/26
1.Revenue & growth
VND bn37,4Q2/26
2.Profit & growth
VND bn-27,4Q2/26
3.Profit mix (Penman)
VND bn-49,5Q2/26
4.Margins & cost structure
%12.5%Q2/26
5.Returns & cash cycle
% · days-0.4%Q2/26
6.Earnings quality & cash
VND bn-81,3Q2/26
7.Asset structure
VND bn1.943Q2/26
8.Funding & debt health
VND bn · times1.943Q2/26
9.Revenue backlog
VND bn2,86Q2/26
10.Valuation
times · %-3,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-209Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-105%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26